Vascular Smooth Muscle Cells

Migration, Crosslink

📖

Vascular Smooth Muscle Cells

active

wiki page Created: 2026-04-02T07:19:38 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-vascular-smooth-muscle-c

📖 Wiki Page

cell1612 wordssynced 2026-04-02

Vascular Smooth Muscle Cells

Introduction

flowchart TD Vascular_Smooth_Muscle_Cells["Vascular Smooth Muscle Cells"] -->|"involved in"| Foam_Cell_Formation["Foam Cell Formation"] Vascular_Smooth_Muscle_Cells["Vascular Smooth Muscle Cells"] -->|"component of"| Neurovascular_Unit["Neurovascular Unit"] style Vascular_Smooth_Muscle_Cells fill:#4fc3f7,stroke:#333,color:#000

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Vascular Smooth Muscle Cells</th>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">alpha-SMA (ACTA2)</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">SM-MYH11</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">Calponin (CNN1)</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">SM22alpha (TAGLN)</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">SM-MHC</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Osteopontin (SPP1)</td>
<td>Increases with dedifferentiation</td>
</tr>
<tr>
<td class="label">MMPs</td>
<td>Increases in disease</td>
</tr>
<tr>
<td class="label">IL-6, TNF-alpha</td>
<td>Increases with senescence</td>
</tr>
<tr>
<td class="label">PDGF-Rbeta</td>
<td>Pericyte communication</td>
</tr>
</table>

...

Vascular Smooth Muscle Cells

Introduction

Mermaid diagram (expand to render)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Vascular Smooth Muscle Cells</th>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">alpha-SMA (ACTA2)</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">SM-MYH11</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">Calponin (CNN1)</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">SM22alpha (TAGLN)</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">SM-MHC</td>
<td>High in contractile state</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Osteopontin (SPP1)</td>
<td>Increases with dedifferentiation</td>
</tr>
<tr>
<td class="label">MMPs</td>
<td>Increases in disease</td>
</tr>
<tr>
<td class="label">IL-6, TNF-alpha</td>
<td>Increases with senescence</td>
</tr>
<tr>
<td class="label">PDGF-Rbeta</td>
<td>Pericyte communication</td>
</tr>
</table>

Vascular smooth muscle cells (VSMCs) are specialized contractile cells that line the walls of cerebral blood vessels, from large conductance arteries to small penetrating arterioles. In the brain, VSMCs play a critical role in regulating cerebral blood flow through vasoconstriction and vasodilation, maintaining the delicate balance required for proper neuronal function. These cells are essential components of the neurovascular unit, working in concert with endothelial cells, pericytes, and neurons to ensure adequate blood supply matches metabolic demands—a process known as neurovascular coupling [@faraci1990][@cipolla2017].

The functional integrity of cerebral VSMCs becomes increasingly important in aging and neurodegenerative diseases. Age-related changes in VSMC function contribute significantly to cerebrovascular dysfunction, which is now recognized as a major contributor to cognitive decline in conditions such as Alzheimer's disease (AD) and vascular dementia [@iadecola2013]. Understanding VSMC biology in the context of the aging brain is essential for developing therapeutic strategies targeting the neurovascular system in neurodegenerative disorders.

Structure and Function

Cellular Morphology

Cerebral VSMCs are elongated, spindle-shaped cells with a characteristic contractile phenotype. They possess:

Actin and myosin filaments: Organized into dense bodies and dense plaques for force generation
Sarcoplasmic reticulum: For calcium storage and release
Mitochondria: Abundant for energy production
Gap junctions: Connecting neighboring VSMCs for coordinated contraction

VSMCs in the cerebral vasculature exhibit remarkable phenotypic plasticity, switching between a contractile (differentiated) state and a synthetic (dedifferentiated) state depending on environmental cues and pathological conditions [@li2023].

Contractile Mechanisms

VSMCs regulate vessel diameter through several key mechanisms:

Calcium-mediated contraction: Activation of L-type voltage-gated calcium channels leads to increased intracellular calcium, which binds calmodulin to activate myosin light chain kinase (MLCK), phosphorylating myosin light chains and enabling cross-bridge cycling with actin.

Membrane receptor pathways: Alpha-adrenergic, serotoninergic, and endothelin receptors couple to G-proteins that either increase calcium or inhibit adenylate cyclase, promoting contraction.

Endothelial-mediated regulation: Endothelium-derived nitric oxide (NO) diffuses into VSMCs to activate guanylyl cyclase, increasing cGMP and promoting relaxation. Conversely, endothelin-1 and thromboxane A2 promote contraction.

Cerebral-Specific Characteristics

Cerebral VSMCs differ from peripheral VSMCs in several important ways:

Greater sensitivity to changes in blood pressure (myogenic tone)
Enhanced response to neuronal activity through neurovascular coupling
Specialized calcium handling mechanisms
Unique receptor expression patterns

Role in Cerebrovascular Health

Regulation of Cerebral Blood Flow

Cerebral VSMCs are primary effectors of cerebral autoregulation, maintaining constant blood flow across a wide range of systemic blood pressures (approximately 60-150 mmHg mean arterial pressure). This protective mechanism ensures consistent oxygen and nutrient delivery to neural tissue regardless of systemic hemodynamic changes [@cipolla2017].

The myogenic response, whereby vessels constrict in response to increased pressure and dilate in response to decreased pressure, is mediated primarily by VSMCs through:

Pressure-sensitive ion channels
Calcium influx through mechanosensitive channels
Activation of protein kinase C (PKC)
Rho-kinase pathway activation

Neurovascular Coupling

VSMCs are essential partners in neurovascular coupling—the process by which increased neuronal activity triggers corresponding increases in blood flow. This involves:

Neuronal activation releases signaling molecules (glutamate, ATP, adenosine)

These signals reach blood vessels through astrocyte endfeet

VSMCs respond by relaxing, dilating the vessel

Enhanced blood flow delivers oxygen and glucose to active neurons

Blood-Brain Barrier Maintenance

VSMCs contribute to blood-brain barrier (BBB) integrity through multiple mechanisms:

Secretion of basement membrane components (collagen IV, laminin)
Regulation of tight junction protein expression in endothelial cells
Production of angiopoietin-1 supporting endothelial barrier function
Coordinated signaling with pericytes for vessel wall stability

Changes in Aging and Neurodegeneration

With aging, cerebral VSMCs undergo significant functional changes [@wong2019][@grigorian2021][@hou2020]:

Increased stiffness: Accumulation of collagen and extracellular matrix proteins reduces vessel compliance

Impaired calcium handling: Altered calcium channel expression and sarcoplasmic reticulum function

Mitochondrial dysfunction: Reduced ATP production and increased oxidative stress

Endothelial-VSMC decoupling: Reduced gap junction communication and altered signaling

Senescent phenotype: Cell cycle arrest with increased pro-inflammatory cytokine secretion (senescence-associated secretory phenotype, SASP)

Telomere shortening: Replicative senescence limits VSMC proliferation and regenerative capacity

Epigenetic changes: DNA methylation and histone modifications alter gene expression patterns

The age-related decline in VSMC function is a major contributor to vascular cognitive impairment, with studies showing that approximately 30-40% of age-related cognitive decline can be attributed to cerebrovascular dysfunction [@jellinger2021].

Alzheimer's Disease Pathology

In Alzheimer's disease, VSMCs are affected by multiple pathological processes [@zlokovic2011][@sagare2012][@tward2023]:

Cerebral Amyloid Angiopathy (CAA): Amyloid-beta (Aβ) deposits in the walls of cerebral vessels, affecting both large arteries and small penetrating arterioles. VSMCs in CAA-affected vessels show:

Degeneration and loss of contractile proteins
Increased matrix metalloproteinase (MMP) activity
Impaired Aβ clearance
Enhanced inflammatory responses [@blixt2020]

The relationship between CAA and VSMC dysfunction is bidirectional—VSMC impairment reduces Aβ clearance from the brain, while Aβ accumulation further damages VSMC function, creating a vicious cycle.

Pericyte-VSMC Interactions: The neurovascular unit relies on coordinated pericyte-VSMC signaling. In AD, pericyte degeneration and reduced PDGFR-β signaling disrupt VSMC regulation of blood flow [@sagare2012][@zhong2021]. This leads to:

Impaired dynamic regulation of cerebral blood flow
Reduced capillary density due to inadequate vessel maintenance
Enhanced BBB leakage

Blood-Brain Barrier (BBB) Breakdown: VSMC dysfunction contributes to BBB compromise through:

Increased MMP activity degrading tight junction proteins
Enhanced leukocyte adhesion and transmigration
Reduced support of endothelial cell function
Altered secretion of basement membrane components

Parkinson's Disease

In Parkinson's disease (PD), VSMC dysfunction contributes to disease progression through:

Reduced cerebral blood flow in specific brain regions
Enhanced neuroinflammation through increased cytokine secretion
Impaired alpha-synuclein clearance from the vasculature
Contributing to Lewy body formation in vascular cells

Vascular Cognitive Impairment

Cerebral small vessel disease (CSVD) is a major cause of vascular cognitive impairment, with VSMC dysfunction as a central feature [@testai2022][@kelley2022][@pantoni2010]:

Fibrinoid necrosis: Wall damage in small arterioles
Lipohyalinosis: Accumulation of lipids and hyaline material
Cholesterol crystal formation: Associated with VSMC degeneration
Laminar necrosis: Loss of VSMC nuclei in vessel walls
Arteriolosclerosis: Hardening and thickening of small arteries

Huntington's Disease

VSMC abnormalities in Huntington's disease include:

Altered vasomotor control
Reduced cerebral blood flow
Contribution to white matter pathology

Molecular Markers

Contractile Markers

Synthetic/Phenotypic Markers

Disease-Associated Markers

Aβ accumulation: APP, Aβ40, Aβ42 deposits in VSMC cytoplasm
Tau pathology: Phosphorylated tau in VSMC nuclei
Oxidative stress: 4-HNE adducts, 8-OHdG
Apoptosis markers: Cleaved caspase-3, TUNEL positivity

Therapeutic Implications

Targeting VSMC Dysfunction

Several therapeutic strategies are being explored to improve VSMC function in aging and neurodegeneration [@grutzendler2022][@maki2022][@matsumoto2022]:

Antihypertensive agents: ACE inhibitors, ARBs show protective effects beyond blood pressure control

Reduce VSMC oxidative stress
Improve endothelial-VSMC communication
Reduce amyloid-induced vasoconstriction

Calcium channel modulators: L-type calcium channel blockers

Reduce intracellular calcium dysregulation
Improve cerebral blood flow autoregulation

Statins: Pleiotropic effects on VSMCs

Reduce oxidative stress
Improve endothelial function
Anti-inflammatory effects

Rho-kinase inhibitors: Direct targets of vasoconstriction

Improve vasodilatory capacity
Reduce cerebral vasospasm

Antioxidants: Mitochondrial-targeted antioxidants

Reduce ROS accumulation
Improve VSMC bioenergetics

Emerging Approaches

Gene therapy: Targeting PDGF-BB for pericyte-VSMC communication
Stem cell therapy: VSMC regeneration or replacement
Senolytics: Selective elimination of senescent VSMCs
BBB repair: Targeting VSMC-endothelial interactions

Clinical Considerations

Several biomarkers are being investigated to assess VSMC health in neurodegenerative diseases:

Cerebral blood flow measurements: Arterial spin labeling MRI
Cerebrovascular reactivity: BOLD fMRI with CO2 challenge
Pulse wave velocity: Assessment of arterial stiffness
Endothelial function tests: Flow-mediated dilation

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[KEGG Pathways](https://www.genome.jp/kegg/pathway.html) - Metabolic pathways

References

[Faraci & Heistad, Regulation of large cerebral artery tone (1990)](https://doi.org/10.1161/01.STR.21.2.199)

[Cipolla, The Cerebral Circulation (2017)](https://doi.org/10.1080/9781498733757)

[Iadecola, The pathobiology of vascular dementia (2013)](https://doi.org/10.1016/j.neuron.2013.10.008)

[Zlokovic, Neurovascular pathways and neurodegenerative disorders (2011)](https://doi.org/10.1038/nrn3114)

[Sagare et al., Pericyte injury and blood-brain barrier dysfunction in AD (2012)](https://doi.org/10.1038/nm.2771)

[Wong et al., Vascular smooth muscle cell dysfunction in aging and AD (2019)](https://doi.org/10.1016/j.tcm.2019.08.001)

[Grigorian et al., Vascular aging and cerebrovascular dysfunction (2021)](https://doi.org/10.1161/STROKEAHA.120.033330)

[Testai et al., Vascular smooth muscle cells in cerebral small vessel disease (2022)](https://doi.org/10.1161/STROKEAHA.121.036900)

[Blixt et al., Cerebral amyloid angiopathy and vascular smooth muscle cells (2020)](https://doi.org/10.1007/s00401-020-02152-8)

[Zhong et al., Pericyte-vascular smooth muscle cell communication in AD (2021)](https://doi.org/10.1093/braincomms/fcab029)

[Kelley et al., Vascular remodeling in vascular cognitive impairment (2022)](https://doi.org/10.1161/STROKEAHA.121.037014)

[Li et al., Smooth muscle cell phenotypic switching in atherosclerosis (2023)](https://doi.org/10.1038/s41569-023-00840-9)

[Hou et al., Age-related vascular dysfunction in neurodegenerative diseases (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.03.017)

[Jellinger, Vascular cognitive impairment and dementia (2021)](https://doi.org/10.1007/s00401-021-02306-4)

[Pantoni, Cerebral small vessel disease (2010)](https://doi.org/10.1016/S1474-4422(10)70006-5)

[Grutzendler et al., Vascular aging in the brain (2022)](https://doi.org/10.1038/s41582-022-00632-9)

[Tward et al., Vascular aging and Alzheimer's disease biomarkers (2023)](https://doi.org/10.1093/braincomms/fcad040)

[Maki et al., Roles of vascular smooth muscle cells in neurodegenerative diseases (2022)](https://doi.org/10.1007/s00401-022-02425-w)

[Matsumoto et al., Cerebrovascular smooth muscle cell heterogeneity in aging (2022)](https://doi.org/10.1161/ATVBaha.122.318235)

📖 View canonical wiki page →

Related Entities

cell-types-vascular-smooth-muscle-cells

▸Metadataorigin_type: v1_polymorphic_backfill

slug	cell-types-vascular-smooth-muscle-cells
kg_node_id	None
entity_type	cell
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-88950e37b910
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-vascular-smooth-muscle-cells'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

90%

Debates

0

Incoming

18

Outgoing

20

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Vascular Smooth Muscle Cells

Vascular Smooth Muscle Cells

Introduction

Vascular Smooth Muscle Cells

Introduction

Structure and Function

Cellular Morphology

Contractile Mechanisms

Cerebral-Specific Characteristics

Role in Cerebrovascular Health

Regulation of Cerebral Blood Flow

Neurovascular Coupling

Blood-Brain Barrier Maintenance

Changes in Aging and Neurodegeneration

Alzheimer's Disease Pathology

Parkinson's Disease

Vascular Cognitive Impairment

Huntington's Disease

Molecular Markers

Contractile Markers

Synthetic/Phenotypic Markers

Disease-Associated Markers

Therapeutic Implications

Targeting VSMC Dysfunction

Emerging Approaches

Clinical Considerations

See Also

External Links

References

💬 Discussion

📗 Cite This Artifact

Vascular Smooth Muscle Cells

Vascular Smooth Muscle Cells

Introduction

Vascular Smooth Muscle Cells

Introduction

Structure and Function

Cellular Morphology

Contractile Mechanisms

Cerebral-Specific Characteristics

Role in Cerebrovascular Health

Regulation of Cerebral Blood Flow

Neurovascular Coupling

Blood-Brain Barrier Maintenance

Changes in Aging and Neurodegeneration

Age-Related Dysfunction

Alzheimer's Disease Pathology

Parkinson's Disease

Vascular Cognitive Impairment

Huntington's Disease

Molecular Markers

Contractile Markers

Synthetic/Phenotypic Markers

Disease-Associated Markers

Therapeutic Implications

Targeting VSMC Dysfunction

Emerging Approaches

Clinical Considerations

See Also

External Links

References

💬 Discussion